Pediatric Obesity Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032) | Key Companies – United Health Group, Rhythm Pharmaceuticals, Novartis Pharmaceuticals,

DelveInsight Business Research LLP

DelveInsight’s “Pediatric Obesity  Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the Pediatric Obesity, epidemiology insights, Pediatric Obesity market trends, therapies, and key companies working in the Pediatric Obesity Market in the 7MM.

Pediatric Obesity Overview

Overweight and obesity are defined as abnormal or excessive fat accumulation that presents a risk to health. A body mass index (BMI) over 25 is considered overweight, and over 30 is obese. Many genetic, physiologic, environmental, and socioeconomic factors influence the development of childhood obesity. 

 Pediatric Obesity Epidemiology Insights 

• The prevalence of obesity among children aged 6 to 11 increased significantly from 4.2% to 15.3%.

• The prevalence of obesity in the United States for children and teens is 18.5%. The rate is even higher for adolescents, at 20.6% for 12 to 19-year-olds.

• Approximately 13.5 million American adolescents struggle with obesity.

Click here to learn more about the Pediatric Obesity Market Landscape

The Report Covers the Pediatric Obesity Epidemiology Segmented by:

• Total Pediatric Obesity incident cases 

• Total Pediatric Obesity prevalent cases 

• Total Pediatric Obesity treatment cases 

• Total Pediatric Obesity diagnostic cases 

Pediatric Obesity Market Outlook 

The Pediatric Obesity market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Pediatric Obesity market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology.

This segment gives a thorough detail of the Pediatric Obesity market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Pediatric Obesity market in 7MM is expected to change in the study period 2019-2032.

Key Companies Working in the Pediatric Obesity Market

• United Health Group 

• Rhythm Pharmaceuticals 

• Novartis Pharmaceuticals

• Eisai Pharmaceuticals 

And many others 

Pediatric Obesity Therapies Covered and Analyzed in the Report

•  VI-0521 mild dose 

•  VI-0521 top dose 

•  Setmelanotide

•  Metformin 

And many others 

Learn more about the Key Companies and Emerging Therapies in the Pediatric Obesity  Market

 Table of Contents 

1. Key Insights 

2. Pediatric Obesity  Introduction 

3. Executive Summary of Pediatric Obesity      

4. Disease Background and Overview

5. Epidemiology and patient population

6. Pediatric Obesity  Emerging Therapies

7. Pediatric Obesity  Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn about the detailed offerings of the report @ Pediatric Obesity Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services